Dr. Michael Chaiton
Michael Chaiton is a Project Lead at the Ontario Tobacco Research Unit and Assistant Professor at the University of Toronto. He has a PhD in Epidemiology from the University of Toronto. He has been active in tobacco control since 2000 when he started working for Physicians for a Smoke-Free Canada and the International Non Governmental Coalition Against Tobacco. He is interested broadly in tobacco research. His main areas of research include unraveling the relationship between depression and smoking in adolescents and understanding the impact of widespread retail availability of tobacco.
Dr. Frank J. Chaloupka
Frank J. Chaloupka is a Distinguished Professor at the University of Illinois at Chicago, where he has been on the faculty since 1988. He is Director of the UIC Health Policy Center and holds appointments in the College of Liberal Arts and Sciences’ Department of Economics and the School of Public Health’s Division of Health Policy and Administration. He is a Fellow at the University of Illinois’ Institute for Government and Public Affairs, and is a Research Associate in the National Bureau of Economic Research’s Health Economics Program and Children’s Program. Dr. Chaloupka is Director of ImpacTeen: A Policy Research Partnership for Healthier Youth Behavior and Co-Director of the International Tobacco Evidence Network. Numerous professional publications and presentations have resulted from Dr. Chaloupka’s research on the effects of economic, policy, and environmental factors on health behavior, including tobacco use, drinking, drug use, diet, physical activity, and related outcomes.
Dr. Paul Clarke
Dr. Paul Clarke received a BA in Experimental Psychology from Cambridge and PhD in Behavioural Neuroscience from University of London’s Institute of Psychiatry. He did postdocs at the National Institute of Mental Health (Biological Psychiatry Branch) in Bethesda, USA, and at UBC (Neurological Sciences). He is currently Professor in the Dept of Pharmacology and Therapeutics at McGill University, and a member of the Center for Studies in Behavioral Neurobiology at Concordia University. He also serves as a Councillor in the Canadian College of Neuropsychopharmacology.
Dr. Clarke’s main research interest is in brain mechanisms underlying drug (especially nicotine) dependence. His research has been conducted mostly in rats and his main contributions (with mentors, colleagues and trainees) are:
- autoradiographic mapping studies of brain nicotinic receptors
- identification of nAChRs on mesolimbic dopamine neurons, and the demonstration that dopaminergic neurons are important for some of the arousing and rewarding effects of nicotine
- the discovery of a compound that blocks brain nicotinic receptors in a quasi-permanent manner
- the finding that rewarding and arousing effects of some drugs (psychomotor stimulants and nicotine) are anatomically segregated in the brain
- development of a new rodent model of intravenous self-administration
Dr. Clarke contributed to the ground-breaking 1988 U.S. Surgeon General’s Report which declared that nicotine addiction was a consequence of cigarette smoking. He has also contributed to smoking-related reports of the Royal Society of Canada and Royal College of Physicians (UK).
Funding: CIHR, NSERC
Dr. Joanna Cohen
Joanna Cohen is the Bloomberg Associate Professor of Disease Prevention and Director of the Institute of Global Tobacco Control in the Department of Health, Behavior and Society at the Johns Hopkins Bloomberg School of Public Health. She also holds an appointment in the Dalla Lana School of Public Health at the University of Toronto and is a Principal Investigator with the Ontario Tobacco Research Unit. Dr. Cohen has been involved in tobacco policy research for 20 years. Trained in epidemiology and health policy, her research interests focus on the factors that affect the adoption and implementation of public health policies and on evaluating the beneficial effects and the unintended consequences of such policies. She is a Senior Editor of Tobacco Control and on the Editorial Board of the Canadian Journal of Public Health, and has been appointed to the Food and Drug Administration’s Tobacco Products Scientific Advisory Committee (2013-2017).
Dr. Timothy Dewhirst
Timothy (Tim) Dewhirst is an Associate Professor in the Department of Marketing and Consumer Studies at the University of Guelph. Much of his research has been substantively focused on tobacco marketing and public policy. More broadly, his research interests include brand strategy, celebrity endorsements, sponsorship-linked marketing, social marketing, and advertising and public policy. He currently teaches courses related to marketing communications and marketing and society (undergraduate level), as well as marketing theory (graduate level).
Dr. Dewhirst is an Associate Editor of the British Medical Journal publication, Tobacco Control, and he also serves on the Editorial Review Board for the Journal of Public Policy and Marketing. Additionally, he served as an invited consultant for the WHO, in which he was named as an expert for the elaboration of a template for a protocol on cross-border advertising, promotion, and sponsorship (with respect to the Framework Convention on Tobacco Control). In 2004, he was a Canada-U.S. Fulbright Scholar, with the University of California, San Francisco (UCSF) serving as a host institution.
Dr. Harry Prapavessis
Guy Faulkner, PhD, is a Professor in the Faculty of Kinesiology and Physical Education. His research focuses on interventions to promote physical activity, and physical activity and mental health. He is a mentor with the CIHR Pan-Canadian Strategic Training Program in Population Intervention Research; an investigator with the Ontario Tobacco Research Unit (OTRU); a Research Affiliate of the Alberta Centre for Active Living; and founding editor of the Elsevier journal Mental Health and Physical Activity. More details of his research can be found at www.epu.utoronto.ca.
Dr. Roberta Ferrence
Roberta Ferrence is Deputy Director (formerly Executive Director) of the Ontario Tobacco Research Unit and Professor in the Dalla Lana School of Public Health at the University of Toronto. She has a Master’s degree in Medical Sociology and a PhD in Epidemiology from the University of Western Ontario. Her research interests include the epidemiology of tobacco use, tobacco policy, health effects of tobacco use, environmental exposures and economic factors in smoking behaviour. Currently, she is involved in qualitative and quantitative research on waterpipe use.
Dr. Geoffrey Fong
Dr. Geoffrey T. Fong is Professor of Psychology and of Public Health and Health Systems at the University of Waterloo; he is also Senior Investigator at the Ontario Institute for Cancer Research. Dr. Fong is Founder and Chief Principal Investigator of the International Tobacco Control Policy Evaluation Project (the ITC Project), a research collaboration of over 100 researchers across 22 countries, inhabited by over 70% of the world’s tobacco users, which has conducted large-scale longitudinal cohort surveys in each country to evaluate the impact of tobacco control policies of the WHO Framework Convention on Tobacco Control (FCTC), such as pictorial health warnings, smoke-free laws, increases in tobacco taxes, and marketing bans. Dr. Fong has published over 220 articles in scientific journals and has contributed to major reports, including the WHO International Agency for Research on Cancer (IARC) Cancer Prevention Handbook on Methods for Evaluating Tobacco Control Policies (2008), the US Institute of Medicine’s Report, Ending the Tobacco Problem (2007), the US Surgeon General’s Report on Preventing Tobacco Use Among Youth and Young Adults (2012). He is one of the three editors (with Frank Chaloupka and Ayda Yurekli) of the forthcoming monograph jointly sponsored by the US National Cancer Institute and the WHO, The Economics of Tobacco and Tobacco Control. Dr. Fong has received major funding for the ITC Project since its beginning, serving as the Principal Investigator or Co-Investigator on grants from the US National Cancer Institute, Canadian Institutes of Health Research, Cancer Research UK, Australia’s National Health and Medical Research Council, and other health research funding sources throughout the world. Dr. Fong was an inaugural recipient (2009) of the “Top Canadian Achievement in Health Research Award” from the Canadian Institutes for Health Research and Canadian Medical Association Journal. He received a Prevention Scientist Award (2011–16) from the Canadian Cancer Society. Dr. Fong received the 2011 CIHR Knowledge Translation Award for his work in disseminating ITC findings to governments, researchers, and advocates throughout the world. In 2012, Dr. Fong and Waterloo colleagues Mary E. Thompson and David Hammond received the Lise Manchester Award from the Statistical Society of Canada for “the unique and historic research effort of the ITC Project.” In May 2013, Dr. Fong was awarded a WHO World No Tobacco Day Award in recognition of his contributions to the implementation of the WHO Framework Convention on Tobacco Control.
Dr. Stanton A. Glantz
Professor Stanton A. Glantz has been a leading researcher and activist in the nonsmokers’ rights movement since 1978, when he helped lead a state initiative campaign to enact a nonsmokers’ rights law by popular vote (defeated by the tobacco industry). In 1983, he helped the successful defense of the San Francisco Workplace Smoking Ordinance against a tobacco industry attempt to repeal it by referendum. The San Francisco victory represented the first electoral defeat of the tobacco industry and is now viewed as a major turning point in the battle for nonsmokers’ rights. He is one of the founders of Americans for Nonsmokers’ Rights. In 1982 he resurrected the film “Death in the West.” He helped write and produce the films “Secondhand Smoke,” which concerns the health effects of involuntary smoking, and “120,000 Lives,” which presents the evidence that smoking in the movies recruits adolescent smokers and offers practical solutions for reducing this effect.
Dr. Glantz conducts research on a wide range of issues ranging from the effects of secondhand smoke on the heart through the reductions in heart attacks observed when smokefree policies are enacted, to how the tobacco industry fights tobacco control programs. His research on the effects of secondhand smoke on blood and blood vessels has helped explain why, in terms of heart disease, the effects of secondhand smoke are nearly as large as smoking. Consistent with what would be expected from the biology of secondhand smoke, he demonstrated a large and rapid reduction in the number of people admitted to the hospital with heart attacks in Helena, Montana, after that community made all workplaces and public places smoke free. His work in this area was identified as one of the “top research advances for 2005″ by the American Heart Association. He was one of the people who first argued that controlling youth access to tobacco products was not an effective tobacco control strategy and was one of the first people to identify the importance of young adults (not just teens) as targets for the tobacco industry and efforts at smoking cessation and tobacco use prevention.
He is author or coauthor of numerous publications related to secondhand smoke and tobacco control, as well as many papers on cardiovascular function and biostatistics. He has written several books, including the widely used Primer of Biostatistics (which has been translated into Japanese, French, Russian, German, Italian, Japanese and Spanish), and Primer of Applied Regression and Analysis of Variance. In total, he is the author of 4 books and nearly 300 scientific papers, including the first major review (published in Circulation) to identify involuntary smoking as a cause of heart disease and the landmark July 19, 1995, issue of JAMA on the Brown and Williamson documents, which showed that the tobacco industry knew 30 years earlier that nicotine was addictive and that smoking caused cancer. This publication was followed by his book, The Cigarette Papers, which has played a key role in the ongoing litigation surrounding the tobacco industry. His book Tobacco Wars: Inside the California Battles chronicles the last quarter century of battles against the tobacco industry in California. He also wrote Tobacco: Biology and Politics for high school students and The Uninvited Guest, a story about secondhand smoke, for second graders. He is now running two educational projects, SmokeFreeMovies.ucsf.edu, which is working to end the use of movies to promote tobacco, and TobaccoScam.ucsf.edu, which is countering tobacco industry efforts to co-opt the hospitality industry.
Working with the UCSF Library, he has taken the lead in making over 62 million pages of previously secret tobacco industry documents available to the entire world via the internet. This effort has help create a whole new area of scientific investigation based on tobacco industry documents.
He served for 10 years as an Associate Editor of the Journal of the American College of Cardiology and is a member of the California State Scientific Review Panel on Toxic Air Contaminants. He was elected to the Institute of Medicine in 2005.
He has traveled widely and lectured on scientific and policy issues related to clean indoor air, smoking in the movies, and effective tobacco control strategies. His work has attracted considerable attention from the tobacco industry, which has sued the University of California (unsuccessfully) twice in an effort to stop Prof. Glantz’ s work. He is a Professor of Medicine (Cardiology) and American Legacy Foundation Distinguished Professor of Tobacco Control as well as Director of the Center for Tobacco Control Research and Education.
Dr. David Hammond
David Hammond is an Associate Professor in the School of Public Health and Health Systems at the University of Waterloo. David’s research focuses on tobacco control policy in the areas of product labelling, risk communication, smoking cessation, and product regulation. He is currently helping to develop standards for testing and regulating cigarettes through the Framework Convention on Tobacco Control. David is also a Co-Investigator on the International Tobacco Control (ITC) Policy Evaluation Survey.
Dr. Alison Holloway
Dr Holloway is an Associate Professor in the Department of Obstetrics and Gynecology at McMaster University. She received her BSc in Zoology from the University of Toronto in 1992 and her PhD in Zoology from the University of Guelph in 1996. She worked as a postdoctoral fellow in the Department of Physiology at the University of Toronto and then in 2003 was offered a faculty position at McMaster University.
Dr. Holloway’s current research studies how exposure to various chemicals during pregnancy can cause damage to the fetus while it is still in the womb. She is also interested in the long-term health consequences of these chemical exposures for the exposed children. The chemicals that are of interest to her laboratory include: chemicals we may intentionally expose ourselves to through lifestyle choices such as cigarette smoking or the use of over the counter natural health products; man-made chemicals present in the environment and naturally occurring chemicals in our diet (e.g., plant phytoestrogens). The majority of the work in her lab at this time focuses on whether children born to women who smoke are more likely to get certain diseases including diabetes and obesity.
Dr. Prabhat Jha
Professor Prabhat Jha has been a key figure in epidemiology and economics of global health for the past decade. He is the University of Toronto Endowed Professor in Disease Control and Canada Research Chair at the Dalla Lana School of Public Health, and the founding Executive Director of the Centre for Global Health Research at St. Michael’s Hospital in Toronto.
Professor Jha is a lead investigator of the Million Death Study in India, which quantifies the causes of premature mortality in over 1 million homes from 1997‐2014 including the contribution of key risk factors such as tobacco, alcohol and diet. He is the author of several influential publications on tobacco control, including two that helped enable a global treaty on tobacco control, now signed by over 160 countries. He is a Series Editor for Disease Control Priorities 3, which examines solutions to major global health challenges. He is a Senior Editor of eLife. Professor Jha publishes widely on cause of death statistics, disease control, tobacco control and economics.
Prior to founding CGHR, Professor Jha served as Senior Scientist for the World Health Organization, where he co‐led the work on health and poverty for the Commission on Macroeconomics and Health. Earlier, he headed the World Bank team responsible for developing the Second National HIV/AIDS Control Program in India. His advisory work has included the Government of South Africa on its national health insurance plan, and the United States Institute of Medicine on global health.
Notable recognitions include Fellowship Award, Canadian Academy of Health Sciences (2013), Officer of the Order of Canada (2012) for services to global health and epidemiology, Luther Terry Award for Research on Tobacco Control (2012), The Globe and Mail 25 Transformational Canadians (2010), Top 40 Canadians under Age 40 Award (2004) and the Ontario Premier’s Research Excellence Award (2004).Professor Jha holds an M.D. from the University of Manitoba and a D.Phil. from Oxford University, where he studied as a Canadian Rhodes Scholar.
Dr. Murray Kaiserman
Murray Kaiserman is the former Director of the Office of Research and Surveillance (Tobacco) within Health Canada’s Controlled Substances and Tobacco Directorate. During his over 20 years at Health Canada, he has directed such surveys as the Canadian Tobacco Use Monitoring Survey (CTUMS) and the Canadian Youth Smoking Survey, as well as research on such issues as health warning messages and the chemistry of tobacco smoke. He has a doctorate from Case Western Reserve University of Cleveland, Ohio, and a Master’s in Business Administration from the University of Ottawa. Since 1989 he has been involved in the development of the Tobacco Act and its Regulations, including two rounds of labelling regulations, as well as the development and implementation of Federal tobacco control strategies such as the Tobacco Demand Reduction Strategy, the Tobacco Control Initiative and the current Federal Tobacco Control Strategy.
Dr. Kelley Lee
Kelley Lee is Professor and Tier 1 Canada Research Chair in Global Health Governance in the Faculty of Health Sciences, Simon Fraser University. She was previously based at the Lonodn School of Hygiene and Tropical Medicine for 20+ years where she led major projects on globalisation and health, tobacco control, global health governance and health diplomacy. Professor Lee has received more than Cdn$17 million in research funding from a broad range of academic research councils, donors governments, UN organisations and charitable foundations. Her current research focuses on the need for collective action to mediate the population health impacts of globalisation. This includes detailed analysis of the tobacco industry. She has authored/co-authored 120+ peer-reviewed papers, 60+ book chapters and 14 books. She has fulfilled several leadership positions including the head of a multidisciplinary research group, head of a large department, director of a WHO collaborating research centre, chair of a WHO scientific committee, and Associate Dean, Research.
Mr. Garfield Mahood
Garfield Mahood is the founder and director of the new non-profit health organization, the Campaign for Justice on Tobacco Fraud. He served for 35 years as the Executive Director of Canada’s Non-Smokers’ Rights Association (NSRA). The NSRA led campaigns in Canada for world precedent-setting legislation to ban tobacco advertising and sponsorship (1988), for landmark tobacco package warning systems (1994 and 2001), for higher tobacco taxation and for tobacco industry denormalization. He has written about and has been the driving force in Canada behind the critical Tobacco Industry Denormalization health strategy.
Under his leadership, the NSRA was the inaugural recipient of the international Luther L. Terry Award established by the American Cancer Society. The award, in the “Outstanding Organization” category, was for global leadership in tobacco control.
In 1990, in tobacco industry documents, Gar was described as the No. 1 threat to the industry in the world at that time.
Gar is the recipient of a World Health Organization gold medal for world leadership in tobacco control and the Canadian Cancer Society’s “Citation of Merit” for “creative and forceful leadership in the cause of cancer prevention.”
In 2007, he was inducted into the Order of Canada as an “Officer”, the second highest rank in Canada’s civilian honour system, for a “lifetime of achievement and merit of a high degree, especially in service to Canada or to humanity at large.”
Dr. Georg Matt
Georg E. Matt, PhD, Professor, Department of Psychology, San Diego State University, is an expert in THS measurements, biomarkers, behaviors and policy implications. His research is focused on designing better strategies to protect nonsmokers from SHS and THS. He has published several important papers on THSand is the lead author of the recently released review paper, “Thirdhand tobacco smoke: emerging evidence and arguments for a multidisciplinary research agenda”.
Dr. Jennifer O’Loughlin
Jennifer O’Loughlin is a Professor at the Centre de recherche CHUM and in the Department of Social and Preventive Medicine at l’Université de Montréal. She is a Canada Research Chair in the Early Determinants of Adult Chronic Disease, and she is also a consultant to the Tobacco Control Research Team at l’Institut national de santé publique du Québec. Areas of research expertise include population-based longitudinal cohort studies in youth and in particular, studies on the acquisition of tobacco use in children and adolescents; school-based research; analysis of longitudinal data; validation of methods to measure smoking, diet, insulin resistance, obesity and physical activity in youth; and evaluation of public health interventions and policy.
Mr. Michael Perley
In April 1993, Michael Perley joined the Ontario Campaign for Action on Tobacco (OCAT) as Campaign Director. On behalf of the Ontario medical and public health communities, Mr. Perley guided the Campaign’s efforts to help pass the Ontario Tobacco Control Act, which made tobacco sales to minors illegal and banned sale of tobacco industry products in pharmacies and vending machines. The Act was proclaimed on November 30, 1994.
Since the act’s passage, Mr. Perley has led or worked with campaigns in support of smoke-free workplace and public place bylaws and legislation in Ontario, Saskatchewan, Manitoba, Quebec, and Nova Scotia. During 2004-2005, the Ontario Campaign worked with the Ontario government to pass legislation mandating 100% smoke-free workplaces and public places and banning retail displays of tobacco industry products province-wide. The Smoke-Free Ontario Act came into force on May 31, 2006.
Mr. Perley then helped lead successful campaigns to implement a ban on smoking in cars transporting children, which was implemented in January 2009, and to pass legislation enabling health care cost recovery litigation against the tobacco industry. The litigation began in the fall of 2009. Most recently, his efforts helped lead to passage of legislation in 2011 that created a number of new contraband control powers for the Ontario government.
The Ontario Campaign’s current objectives include expansion of the Smoke-Free Ontario Strategy, control of contraband tobacco products, regulation of youth-targeted tobacco products such as cigarillos and protection from secondhand smoke in multi-unit dwellings and outdoor public places.
Dr. Andrew Pipe
Dr. Andrew Pipe graduated from Queen’s University in 1974. Currently Chief of the Division of Prevention and Rehabilitation at the University of Ottawa Heart Institute, Dr. Pipe is a Professor in the Faculty of Medicine at the University of Ottawa.
He is currently involved in clinical research assessing new approaches to smoking cessation, strategies designed to facilitate exercise adoption, and novel initiatives to prevent cardiovascular disease.
Dr. Pipe has addressed audiences in over 30 nations and is frequently consulted on issues related to tobacco use and smoking cessation, drug use in sport, and physical activity and health.
A member of the Canadian Olympic Hall of Fame, Dr. Pipe is the recipient of the International Olympic Committee’s Award for “Sport, Health and Wellbeing” and honourary degrees from Queen’s University (LLD), Brock University (DSc) and University of Guelph (DSc). In 2002 he was named to the Order of Canada.
Dr. Peter Selby
Peter Selby MD is the Chief of Addictions and Clinician-Scientist at the Centre for Addiction and Mental Health. He is a Professor in the Departments of Family and Community Medicine and Psychiatry Faculty of Medicine and the Dalla Lana School of Public Health at the University of Toronto. He is the Executive Director and creator of the TEACH (Training Enhancement in Applied Cessation Counselling and Health) project which is a continuing education certificate program through the University of Toronto. Dr. Selby’s research as a Principal Investigator (PI) at the Ontario Tobacco Research Unit includes smoking cessation focusing on smokers with co morbid conditions. As the PI of the STOP program, he investigates effectiveness of NRT and counselling in various treatment settings. He is also the PI of CANADAPTT- a unique Canadian Smoking Cessation Guideline development and dissemination project. Dr. Selby also continues his clinical research with pregnant women who use substances and is the PI of a knowledge translation program (PREGNETS). Peter Selby has received grant funding totaling over 60 million dollars from CIHR, NIH, Ministry of Health and has published 98 peer reviewed publications, 4 books, 24 book chapters, and 12 government research reports.
Dr. Rachel Tyndale
Rachel F. Tyndale, PhD, is a Professor in the Departments of Psychiatry, Pharmacology and Toxicology, at the University of Toronto. She is the Canada Research Chair in Pharmacogenetics, a Senior Scientist and Head of Pharmacogenetics at the Centre for Addiction and Mental Health and the Chair of NIH’s Pharmacogenomics Research Network which consists of 14 scientific and 5 resource hubs. The Tyndale group focuses on pharmacogenetic variation in enzymes and drug targets and the resulting impact on drug dependence, in particular smoking. This has led to the identification of risk factors for use, for amount used and ability to quit (with and without treatment) among different world populations and age groups, ultimately resulting in new strategies for personalization of treatment. She is a member of a number of editorial and scientific advisory boards and is an associate editor for Nature journal’s Clinical Pharmacology and Therapeutics. She is the recipient of a number of awards, most recently the Marsh Endowed Lectureship in Pharmacology and Neurochemistry of Substance Abuse/Addiction Disorders (2012), the Wilkinson memorial lectureship (2012), the Society for Research in Nicotine and Tobacco Langley Award (2012), and the Canadian College of Neuropsychopharmacology Heinz Lehmann Award (2011). Dr. Tyndale has supervised >100 scientists, post-doctoral fellows and students; has published > 200 papers; and has 12 active grants.
Dr. Alex von Gernet
Alex von Gernet has taught at the University of Toronto at Mississauga for over twenty years. He specializes in the history of Aboriginal peoples in North America. Much of his work involves using archaeological data, written documents and oral traditions in litigation and dispute resolution, and he is currently academic advisor to numerous First Nations and Government clients. He is frequently contracted to research and prepare opinion reports and is often called to testify as an expert witness in jurisdictions throughout North America. His interest in tobacco goes back to 1980 when he studied 4,000 Iroquoian ceramic pipes for his Masters Thesis. In 1989 he completed a Doctoral Dissertation on the history of tobacco use among both Aboriginal peoples and European newcomers during the period 1535-1935. He has published occasional scientific papers on the subject ever since.